Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17015817 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorders
Interventions: Drug: Ramelteon;   Drug: Placebo
2 Completed Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse
Condition: Drug Abuse
Intervention: Drug: Ramelteon, triazolam, and placebo (56 possible combinations total)

Indicates status has not been verified in more than two years